title: Pharmacologic management of arrhythmias.
authors.affiliation: Department of Cardiology, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA.
authors.forename: Leila
authors.initials: L
authors.lastname: Ganjehei
authors.forename: Ali
authors.initials: A
authors.lastname: Massumi
authors.forename: Alireza
authors.initials: A
authors.lastname: Nazeri
authors.forename: Mehdi
authors.initials: M
authors.lastname: Razavi
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006329:Heart Conduction System / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D026902:Potassium Channel Blockers / Q000494:pharmacology; D026941:Sodium Channel Blockers / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D026902:Potassium Channel Blockers; D026941:Sodium Channel Blockers